The Biocontrol Agents market is estimated to hit $3.71billion by 2023

In 2017, North America dominates the Biocontrol Agents Market with a share of 38%. Microbials is 79%, while macrobials is 21% in the North America regions.

HYDERABAD, TELANGANA, INDIA, August 6, 2018 / — According to the new market research report by IndustryARC titled “Biocontrol Agents Market: (2018-2023)”, the market is driven by the increasing use of biocontrol agents (BCA) in horticulture. The market value for microbials is improved and this creates more demand for the biocontrol agents. The biocontrol agents are driven by the On-Field application.

North America to have a major share in the Biocontrol Agents Market

In 2017, North America dominates the Biocontrol Agents Market with a share of 38%. Microbials is 79%, while macrobials is 21% in the North America regions. These countries are the largest producers of biocontrol agents. During 2018-2023, the market is expected to grow at a CAGR of 9.86%, with a high demand and requirement for biocontrol agents in countries like the U.S., Canada and Mexico. North American players holds major share of the market owing to the larger production of biocontrol agents in these countries. This factor drives the growth of the biocontrol agents during the forecast period.

Selected / Sample Analysis done in the full Report:

In 2017, On-Field application holds 58% share in the Biocontrol agents Market. Microbials is estimated to have a healthy growth rate from 2018-2023, owing to the increasing demand from the horticulture environment in the U.S., and Canada. Several Biocontrol agents companies in the U.S. are developing new partnerships and investments to harness the latest scientific advances in agricultural biologicals for crop protection and growth. These strategic partnerships and investments will definitely boost the microbial and biocontrol agents market. An advance in the biocontrol agent products increases the demand for biocontrol agents which accelerates the research and development activities.

On-Field application will witness a positive growth by 2023. The overall biocontrol agents market is estimated to reach $3.71 billion by 2023, and bacteria segment will experience a greater demand as they offer good crop yields.

To access / purchase the full report browse the link below

Excerpts on Market Growth Factors

The agriculture industry drives the market of biocontrol agents. There are used in different crop types such as vegetables & fruits, cereals & grains, pulses & oils and others.

The agriculture industry employs biocontrol agents for many applications such as On-Field (Spray), Seed Treatment, and Post-Harvest. Biocontrol Agents are used in horticulture environment and also for out-field crops.

Biocontrol agents’ expansion depends on the growth of microbials such as bacteria, viruses, fungi and entomopathogenic nematodes. Thus microbial products are preferred in the market today.

Talk to one of our sales representative about the full report by providing your details in the link below:

Key players of the Biocontrol Agents market

Bayer CropScience AG is the main company for the production of biocontrol agents in bulk. These biocontrol agents are used in the crop fields. The company has its headquarters in Germany and operates in 79 countries. Syngenta AG which has its headquarters in Switzerland it uses natural biocontrol agent that contains beneficial fungi for corn and peanut crops to reduce alfatoxin contamination levels in crops. It operates in nearly 90 countries in the world. Novozymes A/S (Denmark), BASF SE (Germany) and others are the key players for biocontrol agents market.

Biocontrol Agents market report is segmented as below

Biocontrol agents such as microbials and macrobials are used in On-Field applications. The agriculture industry is the main user of biocontrol agents.

A. Biocontrol Agents by Active Substance
1. Microbials
a. Bacteria
b. Viruses
c. Fungi
d. Entomopathogenic Nematodes
e. Others(Protozoa)
2. Macrobials
a. Predators
b. Parasitoids
c. Weed Killers (Pathogens, Pollinators and Others)
B. Biocontrol Agents by Application
1. On-Field(Spray)
2. Seed Treatment
3. Post-Harvest
C. Biocontrol Agents by Environment
1. Horticulture (Fruits, vegetables, flowers, and many other cultivar)
2. Out Field Crops
D. Biocontrol Agents by Target Post Product
1. Arthropods 
2. Weeds
3. Micro-Organisms
E. Biocontrol Agents by Crop Type
1. Vegetables & Fruits
2. Cereals & Grains 
3. Pulses & Oils 
4. Others
F. Biocontrol Agents by Geography (covers 10+ countries)
G. Biocontrol Agents Market Entropy
H. Companies Citied / Interviewed

1. Andermatt Biocontrol AG
2. Applied Bio-Nomics Ltd. 
3. Arbico Organics 
4. Ausveg
6. Bayer CropScience AG
7. Biobee Biological Systems Ltd. 
8. Biobest N.V.
10. Biocomes
11. Biocontrol Technologies S.L.
12. Bioforce Ltd
13. Bioline Agrosciences Ltd. 
14. Biological Services 
15. BioTech Systems LTD
16. Certis USA LLC
17. Dow AgroSciences LLC
18. Dudutech 
19. DuPont
20. Fargro Ltd. 
21. FMC Corporation
22. Kenogard S.A.
23. Koppert B.V.
24. Marrone Bio Innovations, Inc.
25. Monsanto Company
26. Natural Insect Control
27. Novozymes A/S
28. Sumitomo Chemical Co., Ltd
29. Syngenta AG
30. Tip Top Bio-Control
31. Desarrollo Agrícola y Minero, SA
32. Southeastern Insectaries, Inc.
33. Agrauxine
34. Natural Insect Control
35. Bionema Ltd.
36. Valent BioSciences
37. Yashasvi Agro Tech
38. Nativa SPA.
39. Anatis Bioprotection
40. Applied Bio-nomics Ltd. 

Related Report:

A. Agricultural Inoculants Market

B. Pesticides Market

What can you expect from the report?
The Biocontrol Agents Market Report is Prepared with the Main Agenda to Cover the following 20 points:

1. Market Size by Product Categories & Application 11. Demand Analysis (Revenue & Volume)
2. Market trends & Relevant Market Data 12. Country level Analysis
3. Manufacturer Landscape 13. Competitor Analysis
4. Distributor Landscape 14. Market Shares Analysis
5. Pricing Analysis 15. Value Chain Analysis
6. Top 10 End user Analysis 16. Supply Chain Analysis
7. Product Benchmarking 17. Strategic Analysis
8. Product Developments 18. Current & Future Market Landscape Analysis
9. Mergers & Acquisition Analysis 19. Opportunity Analysis
10. Patent Analysis 20. Revenue and Volume Analysis

Frequently Asked Questions:
Q. Does IndustryARC publish country or application based reports in Biocontrol Agents segment?
Response: Yes, we do have separate reports as mentioned below:

1. North America Biocontrol Agents Market (2018-2023)
2. Asia Pacific Biocontrol Agents Market (2018-2023)
3. Europe Biocontrol Agents Market (2018-2023)

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?
Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interest.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more about our consulting services.

To request for a proposal, provide your details in the below link:

About IndustryARC:

IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences &Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications in a Market. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business.

We look forward to support the client to be able to better address their customer needs, stay ahead in the market, become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Venkat Reddy
email us here

Source: EIN Presswire

ANCON Medical Disease Screening Device Shows Promise for Lyme Disease

Lyme Disease Spread by Ticks

Scanning with NBT

Early Detection of Lyme Disease Possible with ANCON Medical Nanoparticle Biomarker Tagging Technology Device, Further Research

If Lyme disease is discovered early, and treated early, a patient can make a full recovery. But if treatment isn’t delivered until later, a patient can suffer chronic symptoms from the disease”

— Wesley Baker – CEO of ANCON Medical

CANTERBURY, KENT, UNITED KINGDOM, August 6, 2018 / — With the heat of the summer in full fling, outdoor activities like camping and hiking will be part of the fun for many families and individuals. Unfortunately, that also means the risk of Lyme disease, which is most commonly spread through tick bites.

ANCON Medical is looking to introduce revolutionary new technology that can make it easier for doctors to diagnose Lyme disease, for which early treatment can usually result in a rapid and complete recovery, according to the USA Centers for Disease Control.

ANCON Medical’s Nanoparticle Biomarker Tagging (NBT) device can screen for a wide range of diseases by testing an individual’s exhaled breath for biomarkers, which act as a chemical fingerprint for the presence of disease.

Lyme disease is caused by a bacteria and can result in fever, fatigue, skin rash, flu-like symptoms, headaches, joint pains, neck stiffness, heart palpitations and numbness in the face. In the U.S., there were more than 30,000 confirmed reported cases in 2017, with another 10,000 probable cases. There are around 1,000 confirmed cases in the UK each year. Public Health England state that the true number could be around 3,000 per year. However, this number could be much higher.

There are limited testing methods for Lyme disease, which usually begins with doctors examining both the symptoms and possible exposure to ticks. In later stages, the disease can be detected through a blood test, which will often produce negative results in the early stage of the disease.

“If Lyme disease is discovered early, and treated early, a patient can make a full recovery. But if treatment isn’t delivered until later, a patient can suffer chronic symptoms from the disease,” said Wesley Baker, ANCON Medical CEO. “ANCON Medical’s NBT technology has the promise to give doctors early screening capabilities for Lyme disease, allowing for quicker treatment and better results for people infected with the disease.”

To become an effective screening device for Lyme disease, more research and funding will be needed to discover the chemical VOC (volatile organic compound) biomarker for Lyme disease. Furthermore, more research into the Lyme disease biomarker could expand the value of NBT technology to the veterinary field, as the disease has been diagnosed in dogs, cats, horses, goats, sheep and cattle.

In cattle, horses and other livestock, Lyme disease can result in lameness, chronic weight loss and require euthanisation in some cases. Fortunately, Lyme disease can’t be transferred through milk or another contact with livestock, but it can affect an infected cow’s milk production.

“By applying our revolutionary new NBT technology to veterinary medicine, ANCON Medical can make it easier for vets, farmers and agricultural professionals to detect Lyme disease in their animals and better manage their livestock,” Baker said.

ANCON Medical is actively raising investment now to help run trials of its technology to be able potentially to look to help diagnoses of Lyme disease.

Joanna Stephens
Ancon Technologies & Ancon Medical
+44 1227 811705
email us here

Source: EIN Presswire

The 2018-2019 Caitlan Wallace Memorial Scholarship Awarded By Ipe Woods USA Closing Soon

Ipe Woods USA is offering you a chance to secure a $1000 scholarship awarded in the name of Caitlin Wallace.

We are proud to offer a scholarship that will also bring awareness to the exact demographic of individuals that are most affected by unsafe driving.”

— Steven Rossi

REDDING, CALIFORNIA, USA, August 5, 2018 / — Ipe Woods USA has decided to open up a memorial college scholarship program in the name of Caitlin Wallace who lost her life too early. Caitlin had just turned 18 and was excited to get her life started when she lost her life in a car accident. This bright and young hearted girl, who wanted to achieve the world was taken away too soon. Which is why to help remember her dreams Ipe Woods USA is offering a startup college scholarship. The program will initially award you $1000 to get started with college. This scholarship program is set in place to help young adults who have a hard time funding their college journey. The amount is set to help encourage them to get started with college life.

Caitlan Wallace was on her way to start college life and had recently turned 18. When all of her dreams came to an end, and she lost her life on September 29th, 2015. The horrible car accident cost Caitlan her life and left her family and friends in a shock. However, since that day she has been remembered as a witty, spirited, and intelligent young women, who was taken away too soon. In order to keep the memory alive, Ipe Woods USA has started a memorial scholarship in her name. This is the first Caitlan Wallace Memorial scholarship, and it will be awarded to the individual who offers the best essay with their application. Distracted driving is nothing new, but with the addition of cell phones, the statistics are staggering. Reviewing the Teen Safe website and their fact and statistics is very revealing of this epidemic. If considering applying for this application to educate yourself on distracted driving statistics.

Mr. Steven Rossi of Ipe Woods USA USA was a proud uncle. Who wishes to help other students in need. His only wish is to keep the memory of his niece alive by offering other deserving students a chance to make their dreams come to life. Caitlan meant the world to her family and friends and was a constant source of inspiration. Her brilliant mind, and personal charm could easily take over you. While she won't be able to fulfill her college dream, others will have a chance to keep her memory alive. Ipe Woods USA will help a new student get started with college life, and sending a deserving student off to college will help remind him and Caitlin's family of her dreams. And how her memorial scholarship will help make someone's future.

Ipe Woods USA is one of the most trusted lumber company in the USA, as they have been working towards creating a better life for others. Each and every individual looking at IPE understands the importance of quality and safety for them and their family members. Which is why they strive to offer each and every one of them with quality wood. Which is why the essay is based on the importance of following traffic rules, the increasing accidents, and the use of cell phone when driving. By setting the essay topic close to heart, they are able to educate kids about the dangers that are associated with using your phone while driving. When writing the essay for us they will realize how social media has boosted traffic accidents, and how they should all practice safe driving.

The company feels this will really help spread the message, and allow young adults a chance to see how life is precious. How someone who was on their way to fulfill their college dream was taken away in a car accident; and how they can learn from it. The deadline is 1st of November 2018. After which they will review each and every application and essay carefully, before announcing the winner on 15th November. Allowing them to receive the check by 20th November 2018.

You can find more information regarding the essay requirements and scholarship offered by Ipe Woods USA here. Remember never get into a car with anyone that may be under the influence and keep your eyes on the road.

Dale Johnson
Ipe Woods USA
email us here

Source: EIN Presswire

Primetime entered into a CRADA with NIH/NCATS to develop antimicrobial agents for antimicrobial resistant infections

GERMANTOWN, MD, UNITED STATES, August 3, 2018 / — Primetime Life Sciences, LLC has signed a Collaborative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). Working together, Primetime and NCATS will identify, optimize, and develop novel inhibitors of chorismate mutase for the treatment of antimicrobial resistant infections. Under the terms of the agreement, Primetime will collaborate with Dr. James Inglese, who directs the assay development and screening technology laboratory within the NCATS Division of Pre-Clinical Innovation. The scope of the CRADA research plan includes quantitative high throughput screening (qHTS) for the measurement of chorismate mutase (CM) enzymatic activity and lead optimization of the validated hits to identify a preclinical candidate.

The collaboration integrates the capability and expertise Dr. Inglese’s lab at NCATS with the medicinal chemistry and drug development expertise at Primetime to identify a potent and selective inhibitor of chorismate mutase for treatment of microbial infections, particularly Mycobacterium tuberculosis.

“We are delighted to be working with Dr. Inglese and his group at NCATS,” commented Dr. Janak Padia, President, and CEO of Primetime. “The collaboration will bring substantial expertise and resources to discover and develop new chorismate mutase inhibitors for safe and effective treatment for the microbial disease. There is an unmet need for treatment for resistant Mycobacterium tuberculosis, and Primetime is proud to work alongside of NCATS in this endeavor”

Dr. Inglese noted, “We look forward to collaborating with Dr. Padia to discover novel inhibitors for one of nature’s most fascinating catalysts.”


About chorismate mutase:

Chorismate mutase catalyzes the Claisen rearrangement of chorismate to prephenate in the shikimate pathway which leads to the synthesis of the aromatic amino acids phenylalanine and tyrosine. This is the single known example of an enzyme catalyzing a pericyclic reaction. The shikimate pathway for the biosynthesis of aromatic compounds is evidently present in bacteria, fungi, and plants but absent in humans and therefore, chorismate mutase is a valid target for generation of antimicrobial agents and particularly important for drug-resistant bacterial and fungal infections.
About Primetime:

Primetime Life Sciences, LLC ( is an early-stage pharmaceutical company based in Maryland, developing small molecule drugs. Primetime’s mission is to expedite the discovery and development of new and smart treatments by using a multi-
disciplinary, highly collaborative, "bench-to-bedside" approach. Primetime’s translational medicine approach is focused on ensuring proven strategies for disease treatment and prevention.

Primetime has developed preparatory mutual prodrug platform technology (Metual®) to discover and develop small molecule drugs that exert therapeutic effects through synergistic mechanisms with improved drug attributes.

For more information please contact Dr. Janak Padia,

Janak Padia, PhD
Primetime Life Sciences, LLC
email us here

Source: EIN Presswire

Tarps Now Announces New Concrete Curing Blanket Solutionsfor the Construction Industry

New Lines of Standard and Custom Concrete Curing Blankets thatMeet and Exceed the Needs of the Construction Industry

ST. JOSEPH, MICHIGAN, UNITED STATES, August 3, 2018 / — ST. JOSEPH, MICHIGAN, UNITED STATES — Tarps Now® is pleased to announce the addition of new lines of rugged concrete curing blankets that are manufactured using the toughest woven polyethylene fabric, and engineered for correct insulation and extended longevity. In addition, Tarps Now® manufactures these new lines of concrete curing blankets using a flexible foam which provides the highest possible R value factor to accelerate the concrete curing process during all types of weather.

Being highly resilient and hydrophobic, the micro-foam selected by Tarps Now® ensures superior performance, with an outer poly outer shell that is rugged and durable. Each concrete curing blanket features a deep black on the exterior to provide maximum temperature gain from solar heat, thereby maximizing interior insulation layer R values ranging up to 7.7. In addition, wet concrete blankets also are available for ordering where conditions warrant this type of use.

Supporting the new array of Concrete Curing Blankets offered, Tarps Now® provides a variety of stock or standard sizes of concrete curing blankets ranging from 12-mil, 1/2-inch closed cell measuring 3 x 25 feet to 12-mil, to 1/4-inch closed cell blankets that are 12 x 25 feet. Further, as a U.S.-based custom manufacturer of tarps, covers and insulated curing blankets, Tarps Now® produces custom concrete curing blankets sizes for any project.

Tarps Now® Concrete Curing Blankets:

About Tarps Now®

Tarps Now® features an extensive online catalog of canvas tarps, poly tarps, custom tarps, vinyl tarps and industrial divider curtains. As specialists in custom canvas and vinyl tarps, they are the low-price leaders in their category. The company offers the convenience of fast, easy, online ordering as well as a knowledgeable staff to guide customers through the specification process insuring their project will be completed on time and in budget. Tarps Now® has the experience and scale to insure customer specifications are carefully followed and expectations exceeded for every project, large or small.

Michael Dill
Tarps Now, Inc.
email us here

Source: EIN Presswire


Cryptassist Coin ICO

Cryptassist Coin

The Cryptassist ICO is Live Now! Max coin supply 88 Million only. Be part of the amazing Cryptassist ecosystem, a revolutionary crypto platform.

Cryptassist (CTA:CTA)

TALLINN, ESTONIA, August 2, 2018 / — Be part of the amazing Cryptassist ecosystem, a revolutionary crypto platform that will change the way the world views and uses cryptocurrencies.

Cryptassist believe that cryptocurrencies should be useful in everyday life

With 25 apps and features, there is something for everyone, from the absolute novice to the most experienced trader, simplifying the way crypto is used. With one login on either your web or mobile device, you are able to access everything you need. From a fun game, CryptoGo where you can win real crypto, trade on Cryptassist’s own fully licensed spot exchange, shop with your own debit card that can be refilled using any of the top 50 cryptocurrencies, through to a webshop, news updates, every tool a trader needs, forums and much, much more.

The Cryptassist coin (CTA) will run on a blistering fast DAG algorithm and also have a deflationary model where CTA used for premium alerts and services are burned, meaning less CTA potentially increasing the value of the remaining CTA.

Details of the ICO:

Max coin supply 88 Million
31 July 2018 to 12 September 2018 or until hardcap is reached (whichever is earlier)
Maximum of 74.75 M CTA sold during the ICO
3.25 M CTA reserved for the bounty program
10 M CTA reserved for team, exchange listings and promotional activities
Price: $0.38 USD
Hardcap: $23.67 M USD
Softcap: already guaranteed
Platform: DAG

For more details on this exciting opportunity, please visit our website where you can download the Whitepaper and view social media links to Cryptassist.

Connect with Cryptassist:









Telegram Group:

Bitcointalk ANN:

Niki Lin
Cryptassist Corp
email us here

Cryptassist Initial Coin Offering

Source: EIN Presswire